Author

Xiang Wang

Denali Therapeutics (United States)ORCID 0009-0006-8411-3847Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Xiang Wang4 papers · Chinese Academy of Medical Sciences & Peking Union Medical College

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Anastasia G. HenryiD· 1 shared Annie ArguelloiD· 1 shared Ceyda Llapashtica· 1 shared Elvira NegrouiD· 1 shared Hilda O. SolanoyiD· 1 shared Hoang Ngan NguyeniD· 1 shared Laralynne PrzybylaiD· 1 shared Manuel Montalban· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Anastasia G. HenryORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

NeuroscienceScientific ReportsPeer-reviewedJun 18, 2021

Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pRab10

Xiang Wang, Elvira Negrou, Michael T. Maloney…·Anastasia G. Henry

The paper develops and applies quantitative assays to measure LRRK2 and pRab10 levels in cellular models and human subjects to assess LRRK2 kinase activity and its association with Parkinson's disease.

50 citationstop 3%

humanproteomics

𝕏 PostBluesky